Results of the First American Prospective Study of Intravenous Iron in Oral Iron-Intolerant Iron-Deficient Gravidas

American Journal of Medicine

Volumn 130, Issue 12, 2017, Pages 1402-1407

  Auerbach, Michael ^a,b   Bahrain, Huzefa F ^b   James, Stephanie E ^c   Nicoletti, Melissa ^d   Lenowitz, Steven ^d   London, Nicola ^d   Smith, Samuel ^d   Derman, Richard ^e  

^a GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Auerbach Hematology and Oncology   (United States)

^c GEISINGER MEDICAL CENTER   (United States)

^d Franklin Square Hospital Center   (United States)

^e THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Intravenous iron; Iron deficiency anemia; Pregnancy

Indexed keywords

FERRITIN; GLUCOCORTICOID; HEMOGLOBIN; IRON DEXTRAN; TRANSFERRIN; IRON; IRON DERIVATIVE;

ADVERSE OUTCOME; ARTICLE; CESAREAN SECTION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORTICOSTEROID THERAPY; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERANCE; FEMALE; FERRITIN BLOOD LEVEL; FETUS OUTCOME; FOLLOW UP; GASTROINTESTINAL TOXICITY; GROWTH CURVE; HEADACHE; HEMOGLOBIN BLOOD LEVEL; HOT FLUSH; HUMAN; INFANT; IRON DEFICIENCY ANEMIA; MAJOR CLINICAL STUDY; MYALGIA; OPERATIVE BLOOD LOSS; PREGNANCY COMPLICATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; PUERPERIUM; SCORING SYSTEM; SECOND TRIMESTER PREGNANCY; SIDE EFFECT; THIRD TRIMESTER PREGNANCY; VAGINAL DELIVERY; DEFICIENCY; INTRAVENOUS DRUG ADMINISTRATION; ORAL DRUG ADMINISTRATION; PREGNANCY;

ADMINISTRATION, INTRAVENOUS; ADMINISTRATION, ORAL; FEMALE; HUMANS; IRON; IRON COMPOUNDS; PREGNANCY; PREGNANCY COMPLICATIONS; PROSPECTIVE STUDIES;

EID: 85027971607     PISSN: 00029343     EISSN: 15557162     Source Type: Journal    
DOI: 10.1016/j.amjmed.2017.06.025     Document Type: Article

References (28)

1. Breymann, C., Milman, N., Mezzacasa, A., et al. Ferric carboxymaltose vs. oral iron in the treatment of pregnant women with iron deficiency anemia: an international, open-label, randomized controlled trial (FER-ASAP). J Perinat Med 45:4 (2016), 443–453.
2. Congdon, E., Westerlunjd, B., Algarin, C., et al. Iron deficiency in infancy is associated with altered neural correlates of recognition memory at 10 years. J Pediatr 160 (2012), 1227–1233.
3. Radlowski, E., Johnson, R., Perinatal iron deficiency and neurocognitive development. Front Hum Neurosci 7 (2013), 585–592.
4. Lozoff, B., Jimenez, E., Hagen, J., et al. Poorer behavioral and developmental outcome more than 10 years after treatment for iron deficiency anemia in infancy. Pediatrics, 105, 2000, E51.
5. Algarin, C., Peirano, P., Garrido, M., et al. Iron deficiency anemia in infancy: long lasting effects on auditory and visual system functioning. Pediatr Res 53 (2003), 217–223.
6. Tolkien, Z., Stecher, L., Mander, A.P., Pereira, D.I., Powell, J.J., Ferrous sulfate supplementation causes significant gastrointestinal side-effects in adults: a systematic review and meta-analysis. PLoS One, 10(2), 2015, e0117383.
7. Reveiz, I., Gyte, G., Cuervo, L., et al. Treatments for Iron-Deficiency Anaemia in Pregnancy. The Cochrane Collaboration. 2012, Wiley and Sons, Oxford, UK.
8. Drukker, L., Hants, Y., Farkash, R., et al. Iron deficiency anemia at admission for labor and delivery is associated with an increased risk for Cesarean section and adverse maternal and neonatal outcomes. Transfusion 55 (2015), 2799–2806.
9. Khalafallah, A., Dennis, A., Ogden, K., et al. Three-year follow-up of a randomised clinical trial of intravenous versus oral iron for anaemia in pregnancy. BMJ Open, 2(5), 2012, pi:e000998.
10. Wong, L., Smith, S., Gilstrop, M., et al. Safety and efficacy of rapid (1,000 mg in 1 hr) intravenous iron dextran for treatment of maternal iron deficient anemia of pregnancy. Am J Hematol 91 (2016), 590–593.
11. Shi, Q., Li, J., Yao, Q., et al. Intravenous iron sucrose: an alternative for oral iron in pregnancy with iron deficiency anemia. Ann Hematol 94 (2015), 523–525.
12. Reveiz, I., Gyte, G., Cuervo, L., et al. Treatments for iron-deficiency anaemia in pregnancy (Review). Cochrane Database Syst Rev(10), 2011 CD003094.
13. American College of Obstetricians and Gynecologists, ACOG Practice Bulletin No. 95: Anemia in pregnancy. Obstet Gynecol 112 (2008), 201–207.
14. Cantor, A., Bougatsos, C., Dana, M., et al. Routine iron supplementation and screening for iron deficiency anemia in pregnancy: a systematic review for the U.S. Preventive Services Task Force. Ann Intern Med 162 (2015), 566–576.
15. Centers for Disease Control and Prevention, Recommendations to prevent and control iron deficiency in the United States. MMWR Recomm Rep 47 (1998), 1–29.
16. Scholl, T., Hediger, M., Fischer, R., et al. Anemia vs iron deficiency: increased risk of preterm delivery in a prospective study. Am J Clin Nutr 55 (1992), 985–988.
17. Milman, N., Prepartum anaemia: prevention and treatment. Ann Hematol 12 (2008), 949–959.
18. Scholl, T., Hediger, M., Anemia and iron-deficiency anemia: compilation of data on pregnancy outcome. Am J Clin Nutr 59:2 suppl (1994), 492S–500S.
19. Bayoumeu, F., Subiran-Buisset, C., Baka, N., et al. Iron therapy in iron deficiency anemia in pregnancy: intravenous route versus oral route. Am J Obstet Gynecol 186 (2001), 518–522.
20. Avni, T., Bieber, A., Grossman, A., et al. The safety of intravenous iron preparations: systematic review and meta-analysis. Mayo Clin Proc 90 (2015), 12–23.
21. Chandler, G., Harchowal, J., Macdougall, I., Intravenous iron sucrose: establishing a safe dose. Am J Kidney Dis 38 (2001), 988–991.
22. Auerbach, M., Pappadakis, J., Bahrain, H., et al. Safety and efficacy of rapidly administered (one hour) one gram of low molecular weight iron dextran (INFeD) for the treatment of iron deficient anemia. Am J Hematol 86 (2011), 860–862.
23. Auerbach, M., Aygun, A., Auerbach, S., Rapid (60-minute) infusion of one gram of low molecular weight iron dextran: safety and efficacy profile. Presented at; annual meeting of the American College of Obstetricians and Gynecologists, Washington DC, May, 2011.
24. Singh, J., Satele, D., Pattabasavaiah, S., Buckner, J.C., Sloan, J.A., Normative data and clinically significant effect sizes for single-item numerical linear analog self-assessment (LASA) scales. Health Qual Life Outcomes, 12, 2014, 187.
25. Christoph, P., Schuller, C., Studer, H., et al. Intravenous iron treatment in pregnancy: comparison of high-dose ferric carboxymaltose vs. iron sucrose. J Perinat Med 40 (2012), 469–474.
26. Myers, B., Myers, A., Moore, J., Comparative efficacy and safety of intravenous ferric carboxymaltose (Ferinject) and iron(III) hydroxide dextran (Cosmofer) in pregnancy. Obstet Med 5 (2012), 105–107.
27. Ayub, R., Tariq, N., Adil, M., et al. Efficacy and safety of total dose infusion of low molecular weight iron dextran in the treatment of iron deficiency anemia during pregnancy. J Coll Physicians Surg Pak 18 (2008), 424–427.
28. Achebe, M., Gafter-Gvili, A., How I treat anemia in pregnancy: iron, cobalamin, and folate. Blood 129 (2017), 940–949.